Epsilon Healthcare (FRA:9TH0) Debt-to-EBITDA : 3.46 (As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Epsilon Healthcare Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Epsilon Healthcare's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was €1.54 Mil. Epsilon Healthcare's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was €0.18 Mil. Epsilon Healthcare's annualized EBITDA for the quarter that ended in Jun. 2023 was €0.50 Mil. Epsilon Healthcare's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2023 was 3.46.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Epsilon Healthcare's Debt-to-EBITDA or its related term are showing as below:

FRA:9TH0' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.87 Med: -0.3 Max: -0.05
Current: -0.87

During the past 6 years, the highest Debt-to-EBITDA Ratio of Epsilon Healthcare was -0.05. The lowest was -0.87. And the median was -0.30.

FRA:9TH0's Debt-to-EBITDA is not ranked
in the Drug Manufacturers industry.
Industry Median: 1.69 vs FRA:9TH0: -0.87

Epsilon Healthcare Debt-to-EBITDA Historical Data

The historical data trend for Epsilon Healthcare's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epsilon Healthcare Debt-to-EBITDA Chart

Epsilon Healthcare Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-EBITDA

Get a 7-Day Free Trial

-0.05

-0.06

-0.60

-0.54

-0.30

Epsilon Healthcare Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Debt-to-EBITDA	Get a 7-Day Free Trial								-0.63	-0.47	-0.20	-0.44	3.46

Competitive Comparison of Epsilon Healthcare's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Epsilon Healthcare's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Epsilon Healthcare's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Epsilon Healthcare's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Epsilon Healthcare's Debt-to-EBITDA falls into.

Epsilon Healthcare Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Epsilon Healthcare's Debt-to-EBITDA for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(1.624	+	0.413)	/	-6.915
	=	-0.29

Epsilon Healthcare's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(1.539	+	0.183)	/	0.498
	=	3.46

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Jun. 2023) EBITDA data.

Epsilon Healthcare (FRA:9TH0) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Epsilon Healthcare Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Epsilon Healthcare's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Epsilon Healthcare (FRA:9TH0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Epsilon Healthcare Ltd (FRA:9TH0) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

EPN:Australia

Address

35 Lime Street, Suite 305, Level 3, Sydney, NSW, AUS, 2000

Website

https://www.epsilonhealthcare.com.au

Epsilon Healthcare Ltd is a diversified global healthcare and pharmaceuticals company. It owns number of medicinal cannabis assets including the cannabis manufacturing facility in the Southern Hemisphere, the Tetra Health clinic, and the Medimar Platform an end to end ecommerce solution for nutraceuticals and cannabis. EPN additionally operates a turn-key cannabis cultivation solutions provider based in Vancouver, Canada.

Epsilon Healthcare (FRA:9TH0) Headlines

No Headlines